January 13, 2023
Following a series of sales suspensions for drugs containing nizatidine, Yoshindo on January 11 initiated a voluntary recall for some lots of its 150 mg tablet product over carcinogen risks. This leaves Zeria Pharmaceutical’s original drug Acinon (nizatidine) to become...read more